Motif-grafted hybrid polypeptides and uses thereof

Details for Australian Patent Application No. 2003231995 (hide)

Owner The Scripps Research Institute

Inventors Moroncini, Gianluca; Burton, Dennis R.; Williamson, R. Anthony

Agent Spruson & Ferguson

Pub. Number AU-B-2003231995

PCT Number PCT/US03/10856

PCT Pub. Number WO2003/085086

Priority 60/371,610 09.04.02 US

Filing date 8 April 2003

Wipo publication date 20 October 2003

Acceptance publication date 27 November 2008

International Classifications

C07K 1/00 (2006.01) General processes for the preparation of peptides

A61K 38/00 (2006.01) Medicinal preparations containing peptides

C07K 2/00 (2006.01) Peptides of undefined number of amino acids

C07K 4/00 (2006.01) Peptides having up to 20 amino acids in an undefined or only partially defined sequence

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/10 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 16/42 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against immunoglobulins (anti-idiotypic antibodies)

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

C07K 17/00 (2006.01) Carrier-bound or immobilised peptides

C07K 19/00 (2006.01) Hybrid peptides

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

28 August 2003 Complete Application Filed

  Priority application(s): 60/371,610 09.04.02 US

27 November 2003 Application Open to Public Inspection

  Published as AU-B-2003231995

27 November 2008 Application Accepted

  Published as AU-B-2003231995

26 March 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003231996-METHOD FOR CUTTING SINGLEWALL CARBON NANOTUBES THROUGH FLUORINATION

2003231994-NANOPARTICLE DELIVERY SYSTEMS AND METHODS OF USE THEREOF